Bruno Cadot

Bruno Cadot is a researcher and head of the imaging platform at Institut de Myologie since January 2013. Previous experience includes a postdoctoral researcher position at Sorbonne Université from January 2008 to December 2012, and a similar role at INSERM for a brief period in 2007, focusing on muscle fiber structure. Bruno Cadot also held a postdoctoral position at Merck from December 2004 to July 2007, demonstrating that HDAC4 silencing induces cell death in cancer cells. Educational qualifications include a PhD in Biochemistry and Cell Biology from Pierre and Marie Curie University, as well as a Doctor of Philosophy in Cellular and Molecular Biology from the University of Rome "Tor Vergata." Earlier academic achievements include master's degrees in Biochemistry and a degree in Biochemistry from Université Paris Cité.